CLSA Premium Ltd. stock analysis
Want to see HK:6877 full AI Analyst Report?
CLSA Premium Ltd. (6877) Stock Price & Analysis
6877 Stock Chart & Stats
- Day’s Range
- HKD 0.09 - HKD 0.09
- 52-Week Range
- HKD 0.08 - HKD 0.24
- Previous Close
- HKD 0.09
- Volume
- N/A
- Average Volume (3M)
- 111.50K
- Market Cap
- HKD 183.00M
- Enterprise Value
- HKD 2.69M
- Total Cash (Recent Filing)
- HKD 212.84M
- Total Debt (Recent Filing)
- HKD 0
- Price to Earnings (P/E)
- ―
- Beta
- 0.12
- Next Earnings
- Mar 15, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- May 19, 2015
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Gross-Margin Recovery
The sharp revenue rebound and substantial gross-margin improvement indicate stronger business activity alongside better pricing, mix, or cost control. If maintained, this combination can improve operating leverage and provide a stronger foundation for returning the brokerage business to sustainable profitability.
Debt-Free Balance Sheet
A debt-free balance sheet reduces interest burden, refinancing exposure, and financial fragility during weaker operating periods. The stable equity base also gives CLSA Premium greater flexibility to absorb losses, maintain regulatory capital, and fund operations while pursuing recovery.
Demonstrated Prior Profitability
Profitability in 2023 and 2024 shows that the business has previously converted operations into positive earnings, rather than being structurally loss-making in every period. That history provides evidence of potential earnings capacity if the recent revenue and margin recovery proves durable.
Bears Say
Ongoing Net Losses
The current revenue recovery has not yet translated into sustained earnings, leaving the company exposed to continued operating losses. Persistent negative net income can erode the capital base over time and limits internally generated resources available for investment, resilience, or shareholder returns.
Persistent Negative Cash Generation
Recurring negative operating and free cash flow is a fundamental weakness because reported business activity is not consistently producing cash. Even without debt, ongoing cash deficits can pressure liquidity, reduce strategic flexibility, and require the company to rely on its existing capital base.
Weak Returns On Capital
Negative return on equity indicates that the company is currently not generating positive returns from its substantial capital base. This weak capital productivity reinforces the profitability concern and may limit the long-term value of maintaining excess financial capacity unless operating performance improves.
CLSA Premium Ltd. News
Top Eminent Healthcare Faces Adverse Court Ruling in Banclogix Dispute
CLSA Premium Ltd. ( ($HK:6877) ) has provided an update. Top Eminent Healthcare Group Limited, a Hong Kong-listed healthcare group incorporated in the Cayman Islands, operates through subsidiaries providing healthcare-related
6877 FAQ
What was CLSA Premium Ltd.’s price range in the past 12 months?
What is CLSA Premium Ltd.’s market cap?
When is CLSA Premium Ltd.’s upcoming earnings report date?
How were CLSA Premium Ltd.’s earnings last quarter?
Is CLSA Premium Ltd. overvalued?
Does CLSA Premium Ltd. pay dividends?
What is CLSA Premium Ltd.’s EPS estimate?
How many shares outstanding does CLSA Premium Ltd. have?
What happened to CLSA Premium Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of CLSA Premium Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
CLSA Premium Ltd.
Engaged in the distribution of health-related goods and services, Top Eminent Healthcare Group Limited operates as an investment holding company, with its activities spanning Australia, Hong Kong, and New Zealand.
- Sector
- Financial
- Industry
- Financial - Capital Markets
- CEO
- Guangfei Ji
- Employees
- 15
- Website
- www.tehealth.com
- Address
- HK
CLSA Premium Ltd. (6877) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 4 | 3 | 3 |
| Moving Averages | 1 | 0 | 11 |









